The calcimimetic calindol prevents high phosphate-induced vascular calcification by upregulating matrix GLA protein

Nephron - Experimental Nephrology

Volumn 122, Issue 3-4, 2013, Pages 75-82

  Ciceri, Paola ^a   Elli, Francesca ^a   Brenna, Irene ^a   Volpi, Elisa ^a   Brancaccio, Diego ^a   Cozzolino, Mario ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Calcimimetic; Matrix Gla protein; Vascular calcification

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIMIMETIC AGENT; CALCIUM; CALINDOL; OSTEOCALCIN; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR MATRIX PROTEINS; INDOLES; MALE; MUSCLE, SMOOTH, VASCULAR; NAPHTHALENES; PHOSPHATES; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; VASCULAR CALCIFICATION;

EID: 84875661198     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000349935     Document Type: Article

References (30)

1. Tonelli M, Pannu N, Manns B: Oral phosphate binders in patients with kidney failure. N Engl J Med 2010; 362: 1312-1324.
2. Brancaccio D, Cozzolino M, Cannella G, et al: Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality. Blood Purif 2011; 32: 124-132.
3. Lopez I, Aguilera-Tejero E, Mendoza FJ, et al: Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol 2006; 17: 795-804.
4. Alam MU, Kirton JP, Wilkinson FL, et al: Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 2009; 81: 260- 268.
5. Caudrillier A, Mentaverri R, Brazier M, et al: Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease. J Nephrol 2010; 23: 17-22.
6. Ciceri P, Volpi E, Brenna I, et al: Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation. Nephrol Dial Transplant 2012; 27: 122-127.
7. Jono S, McKee MD, Murry CE, et al: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: 10-17.
8. Steitz SA, Speer MY, Curinga G, et al: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfα1 and downregulation of smooth muscle lineage markers. Circ Res 2001; 89: 1147-1154. (Pubitemid 34627872)
9. Ducy P, Zhang R, Geoffroy V, et al: Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754. (Pubitemid 27516177)
10. Cozzolino M, Brancaccio D, Gallieni M, et al: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005; 68: 429-436. (Pubitemid 43323098)
11. Krueger T, Westenfeld R, Schurgers LJ, Brandenburg VM: Coagulation meets calcification: the vitamin K system. Int JArtif Organs 2009; 32: 67-74.
12. Luo G, Ducy P, McKee MD, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81. (Pubitemid 27130923)
13. Mendoza FJ, Martinez-Moreno J, Almaden Y, et al: Effect of calcium and the calcimimetic AMG 641 on matrix-Gla protein in vascular smooth muscle cells. Calcif Tissue Int 2011; 88: 169-178.
14. Farzaneh-Far A, Proudfoot D, Weissberg PL, Shanahan CM: Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun 2000; 277: 736-740.
15. Molostvov G, Fletcher S, Bland R, Zehnder D: Extracellular calcium-sensing receptor mediated signalling is involved in human vascular smooth muscle cell proliferation and poptosis. Cell Physiol Biochem 2008; 22: 413-422.
16. Ciceri P, Volpi E, Brenna I, et al: The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification. Biochem Biophys Res Commun 2012; 418: 770-773.
17. Giachelli CM, Speer MY, Li X, et al: Regulation of vascular calcification. Roles of phosphate and osteopontin. Circ Res 2005; 96: 717- 722. (Pubitemid 40559510)
18. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-1731. (Pubitemid 35286280)
19. Bobryshev YV: Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol 2005; 205: 641-650. (Pubitemid 40514838)
20. Shanahan CM, Cary NR, Salisbury JR, et al: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-2176.
21. Brancaccio D, Biondi ML, Gallieni M, et al: Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol 2005; 25: 548-552. (Pubitemid 41816049)
22. Lopez I, Mendoza FJ, Aguilera-Tejero E, et al: The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int 2008; 73: 300-307.
23. Koleganova N, Piecha G, Ritz E, et al: A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 2009; 75: 60-71.
24. Ivanovski O, Nikolov IG, Joki N, et al: The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE -/-) mice. Atherosclerosis 2009; 205: 55-62.
25. Lopez I, Mendoza FJ, Guerrero F, et al: The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats. Am J Physiol Renal Physiol 2009; 296:F1376- F1385.
26. Urena Torres PA, De Broe M: Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int 2012; 82: 19-25.
27. Raggi P, Chertow GM, Torres PU, et al, ADVANCE Study Group: The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011; 26: 1327-1339.
28. Lacolley P, Regnault V, Nicoletti A, et al: The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 2012; 95: 194-204.
29. Collett G, Wood A, Alexander MY, et al: Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res 2003; 92: 1123-1129. (Pubitemid 36665858)
30. Son BK, Kozaki K, Iijima K, et al: Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 2006; 98: 1024-1031.